PNPLA3 I148M polymorphism and progressive liver disease. - Wikidata - wikimedia - TriplyDB

PNPLA3 I148M polymorphism and progressive liver disease.

PNPLA3 I148M polymorphism and progressive liver disease.

http://www.wikidata.org/entity/Q37285240

about

A Meta-Analysis of the Association Between the I148M Variant of Patatin-Like Phospholipase Domain Containing 3 Gene and the Presence of Chronic Hepatitis C Chemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agents Alcoholic liver disease and hepatitis C virus infection Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis Composite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countries Insulin resistance in clinical and experimental alcoholic liver disease Molecular Pathogenesis of NASH Omic studies reveal the pathogenic lipid droplet proteins in non-alcoholic fatty liver disease.Understanding the pathophysiological mechanisms in the pediatric non-alcoholic fatty liver disease: The role of genetics.The Association between Pediatric NAFLD and Common Genetic Variants.MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals.Nonalcoholic fatty liver disease and polycystic ovary syndrome.Interaction between PNPLA3 I148M variant and age at infection in determining fibrosis progression in chronic hepatitis C.Future therapy of portal hypertension in liver cirrhosis - a guess.Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis The rs738409 (I148M) variant of the PNPLA3 gene and cirrhosis: a meta-analysis Influence of the PNPLA3 rs738409 Polymorphism on Non-Alcoholic Fatty Liver Disease and Renal Function among Normal Weight Subjects.Influence of ethnicity on the distribution of genetic polymorphisms associated with risk of chronic liver disease in South American populations.PNPLA3 I148M Variant Influences Circulating Retinol in Adults with Nonalcoholic Fatty Liver Disease or Obesity.Calcium-independent phospholipases A2 and their roles in biological processes and diseases.Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research Pathophysiology of lipid droplet proteins in liver diseases.PNPLA3 148M Carriers with Inflammatory Bowel Diseases Have Higher Susceptibility to Hepatic Steatosis and Higher Liver Enzymes.Genetic factors that affect nonalcoholic fatty liver disease: A systematic clinical review.Genetic Variations Associated with Vitamin A Status and Vitamin A Bioavailability.Systematic review with meta-analysis: the I148M variant of patatin-like phospholipase domain-containing 3 gene (PNPLA3) is significantly associated with alcoholic liver cirrhosis.Recent advances in hemochromatosis: a 2015 update : a summary of proceedings of the 2014 conference held under the auspices of Hemochromatosis Australia.Natural antioxidants for non-alcoholic fatty liver disease: molecular targets and clinical perspectives.The role of insulin resistance in nonalcoholic steatohepatitis and liver disease development--a potential therapeutic target?A Nutrigenomic Approach to Non-Alcoholic Fatty Liver Disease.Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease.Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?Nonalcoholic fatty liver disease: one entity, multiple impacts on liver health.Type 2 Diabetes and Hepatocellular Carcinoma: Risk Factors and Pathogenesis.Significance of genetic polymorphisms in patients with nonalcoholic fatty liver disease.Lipid droplets and liver disease: from basic biology to clinical implications.Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease.Fatty liver without a large "belly": Magnified review of non-alcoholic fatty liver disease in non-obese patients.PNPLA3 polymorphisms (rs738409) and non-alcoholic fatty liver disease risk and related phenotypes: a meta-analysis.Regulation of retinol-binding protein 4 and retinol metabolism in fatty liver disease.

P2860

Q26770432-2855049A-CCDA-4D02-9BEE-3815DB9638BC Q26772302-CC5534D6-8EAA-484D-A00C-9833736D665E Q26773274-5CD1F287-26AA-4D05-AE0F-2633AF37130E Q26798151-16FD947D-82EE-44AA-82AC-792C947416F1 Q26828855-3194F297-E184-4A03-938C-CA07D71A5676 Q26865988-226299A6-FF39-421D-85B1-90D73E86D9E8 Q28071265-9ED0C74D-FBD7-4B50-800F-9F3C50D92514 Q30244335-0957A8C7-0C88-4220-93A6-8EFA04E7E6EF Q33360950-24B5D71F-9075-4E73-91DB-A1B42BB7442F Q33831722-983DED0B-1399-4098-A9D3-FB570D06827B Q33866766-27A2E889-4E6D-4C2F-8BC5-60B0F438A181 Q33886930-D7DD5E94-CF90-4612-A87A-2E681CEEBCF5 Q34110246-52025D1B-7586-409B-89EF-2BD109DCEAF6 Q34446521-B7251F92-E2B6-47FD-B2A1-9C53B068F9FB Q34675058-6CD91BAE-A6B4-4452-95B8-6C05CD220A8A Q34757399-C0575A5C-5D24-41D6-B2F0-B5B177005BAC Q35704998-635C2854-C1D4-480E-B26E-9611580C5A27 Q35720903-1DDF56FC-DB91-4995-8618-F830FDB3F2FE Q35894263-01014DC8-BFC1-413F-A05D-A57CC9EE78C2 Q35994344-EB6B913C-D85A-417F-86F9-5A1FC7215C88 Q36129673-3BCB5303-115B-4935-82B7-BE0CB292417E Q36553968-A0550386-A8EC-415F-A6B5-9D2EC9BD9134 Q36973400-088CA677-8F16-4123-88C1-75918E707474 Q37146192-C0519A0A-C4A8-4BA6-85CD-2F597DDB3695 Q37729744-74F02E5F-C581-4918-A287-9BAEDC4FAEBC Q38233721-E29AE095-0FAB-4101-AFCB-6EB46A4B40CB Q38383414-2F13F053-DE97-48AF-89ED-DD8ED106F493 Q38599131-3D1AD4EE-E665-4982-B851-57FB9C37BCE2 Q38660769-0D01D46A-8034-4948-9237-E61E29EB60F1 Q38675911-A554B30E-5030-4D4D-819F-B0C061C207C4 Q38711424-1244161E-246C-45D6-BF39-85EEEEB70D04 Q38859044-5CACE8CF-8FF0-4C6C-92AB-1569F582DDA7 Q38966889-9D5B75FD-2798-4BD4-A813-C3F02347D1E8 Q39177080-8B491309-61D7-49EA-BE4D-3216332E3A60 Q39177106-BD8F189E-6C9D-41B0-960F-8543CD913ADA Q39253589-0EF49A50-80B3-4A93-A33E-35E07C1B9071 Q41050215-9228020E-EC3C-4227-A686-A0A9A137A464 Q41449920-A249FABC-8D44-4C18-A23A-53944A6A8D57 Q41495808-F11928A0-9733-419A-B38C-EF56882B8159 Q42361308-3323E4D7-0F97-4BFB-837A-95282147862C

P2860

PNPLA3 I148M polymorphism and progressive liver disease.

http://www.wikidata.org/entity/Q37285240

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

PNPLA3 I148M polymorphism and progressive liver disease.

@en

PNPLA3 I148M polymorphism and progressive liver disease.

@nl

type

label

PNPLA3 I148M polymorphism and progressive liver disease.

@en

PNPLA3 I148M polymorphism and progressive liver disease.

@nl

prefLabel

PNPLA3 I148M polymorphism and progressive liver disease.

@en

PNPLA3 I148M polymorphism and progressive liver disease.

@nl

P1433

Q37285240-34F762B9-4D63-4ADB-9F09-814A69BCC755

P1476

Q37285240-B8CF4B96-3336-4642-960A-F55F111CE2EF

P2093

Q37285240-4DBF61B7-1335-4404-AAAB-7E81E8D28ADF

Q37285240-91F9442D-F6C1-459A-B380-EA33943BD697

P2860

Q37285240-018365C6-D28B-4C23-B186-23B68606E7E3

Q37285240-0427C2FF-A6F1-4903-A920-CD51FE249604

Q37285240-0CB485A0-3D45-4E97-A287-2D0EDC136B9B

Q37285240-0DF2CAAD-9EF0-4C32-97A0-A65F92ADA8A3

Q37285240-0E605395-855A-4ED4-ADC7-007B08AF132C

Q37285240-1038E62E-0B1D-4C4E-B50B-230E8F75924D

Q37285240-10B5625C-236D-430C-80E4-859FADD8D715

Q37285240-128BFE0C-EF3C-434A-B25F-BFA1AC4333CF

Q37285240-1471F7A1-5457-4539-887E-B2487A2D7E0B

Q37285240-17BC0AA4-6181-48A0-8E95-475C8AD890B2

P304

Q37285240-F0257319-9B05-41C5-9E11-9914E6380335

P31

Q37285240-9E4F8AC2-9ACF-448D-9912-26ABFE7A7D6C

P356

Q37285240-FF948F3B-2711-4C12-ADA6-FDE883214031

P407

Q37285240-68126884-E7E4-4074-92B4-35435B1A1031

P433

Q37285240-18BE97B9-4221-45D4-B277-A93FA1C82EB5

P478

Q37285240-B5864246-4239-45BC-B205-F56BF8754A06

P50

Q37285240-348BCB8E-5A5D-488B-9AE8-556AFCB13F4E

Q37285240-35A087D3-62E6-4166-AF36-271EC1A50A62

Q37285240-36E4E2ED-C4EB-455B-909B-5CB6850F46EC

Q37285240-6539642B-43D0-433C-B1E9-3FCF7656FD1D

Q37285240-7D0A6F73-DE3D-405E-965C-B3E26ADEA97B

P577

Q37285240-26CE4B77-1144-46F0-B04D-E54B3D1F0704

P5875

Q37285240-9FD9D58F-139A-4F0E-9442-D0E41C10D988

P698

Q37285240-7CFEDF45-B5AC-4DFF-9C06-FC93F12737F5

P932

Q37285240-BD2ED5CF-E56F-4ACC-A0A9-EF0DE3C0D75F

P356

WJG.V19.I41.6969

P1433

World Journal of Gastroenterology

P1476

PNPLA3 I148M polymorphism and progressive liver disease.

@en

P2093

Paola Dongiovanni

http://www.w3.org/2001/XMLSchema#string

Roberta Fares

http://www.w3.org/2001/XMLSchema#string

P2860

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

Nonalcoholic Fatty Liver Disease: A Feature of the Metabolic Syndrome

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase.

Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third National Health and Nutrition Examination Survey.

The burden of liver disease in Europe: a review of available epidemiological data.

P304

6969-6978

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V19.I41.6969

http://www.w3.org/2001/XMLSchema#string

P407

P433

41

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

Benedetta Donati

Rosellina Margherita Mancina

P577

2013-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258504019

http://www.w3.org/2001/XMLSchema#string

P698

24222941

http://www.w3.org/2001/XMLSchema#string

P932

3819533

http://www.w3.org/2001/XMLSchema#string